APA-viite

Dayal, S., Aluri, J., Hall, N., Filippov, G., Moline, M., Reyderman, L., & Landry, I. (2021). Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant. Pharmacol Res Perspect.

Chicago-tyylinen lähdeviittaus

Dayal, Satish, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Margaret Moline, Larisa Reyderman, ja Ishani Landry. "Effect of Hepatic Impairment On Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacol Res Perspect 2021.

MLA-viite

Dayal, Satish, et al. "Effect of Hepatic Impairment On Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacol Res Perspect 2021.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.